Intestinal necrosis after co-administration of sodium polystyrene sulfonate and activated charcoal.
activated charcoal
end‐stage renal disease
intentional drug overdose
kayexalate
kidney transplant
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
13
12
2019
revised:
09
01
2020
accepted:
15
01
2020
entrez:
11
4
2020
pubmed:
11
4
2020
medline:
11
4
2020
Statut:
epublish
Résumé
Development of acute abdominal pain after Kayexalate and activated charcoal administration should prompt clinician to consider intestinal necrosis. Concomitant use should be avoided to minimize the risk of this devastating but preventable condition.
Identifiants
pubmed: 32274045
doi: 10.1002/ccr3.2695
pii: CCR32695
pmc: PMC7141745
doi:
Types de publication
Case Reports
Langues
eng
Pagination
722-724Informations de copyright
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
None.
Références
Surgery. 1987 Mar;101(3):267-72
pubmed: 3824154
Ann Surg. 1976 Jan;183(1):77-83
pubmed: 1108814
Am J Ther. 2016 Jul-Aug;23(4):e1102-4
pubmed: 25415544
Am J Med. 2013 Mar;126(3):264.e9-24
pubmed: 23321430
Intern Med. 2018 Jun 1;57(11):1577-1581
pubmed: 29321412
PLoS One. 2015 Sep 28;10(9):e0137636
pubmed: 26413782
South Med J. 2009 May;102(5):493-7
pubmed: 19373153
Am J Surg Pathol. 1997 Jan;21(1):60-9
pubmed: 8990142
J Trauma. 2001 Aug;51(2):395-7
pubmed: 11493807